These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31932840)

  • 21. Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience.
    Castelli M; Micò MC; Grassi A; Algarotti A; Lussana F; Finazzi MC; Rambaldi B; Pavoni C; Rizzuto G; Tebaldi P; Vendemini F; Verna M; Bonanomi S; Biondi A; Balduzzi A; Rambaldi A; Gotti G
    Bone Marrow Transplant; 2024 Aug; 59(8):1161-1168. PubMed ID: 38773280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy.
    Dandoy CE; Tsong WH; Sarikonda K; McGarvey N; Perales MA
    Transplant Cell Ther; 2023 Apr; 29(4):282.e1-282.e9. PubMed ID: 36592719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation.
    El-Bietar J; Warren M; Dandoy C; Myers KC; Lane A; Wallace G; Davies SM; Jodele S
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1994-2001. PubMed ID: 26150023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective study.
    Laber DA; Patel PC; Logothetis CN; Patel AK; Jaglal M; Haider M; Visweshwar N; Rajasekaran-Rathnakumar G; Eatrides J
    Eur J Haematol; 2024 Mar; 112(3):450-457. PubMed ID: 37984551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.
    Boudhabhay I; Rabant M; Roumenina LT; Coupry LM; Poillerat V; Marchal A; Frémeaux-Bacchi V; El Karoui K; Monchi M; Pourcine F
    Front Immunol; 2021; 12():680567. PubMed ID: 34248962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy.
    Gabr JB; Bilal H; Mirchia K; Perl A
    J Investig Med High Impact Case Rep; 2020; 8():2324709620947266. PubMed ID: 32757799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplant-associated thrombotic microangiopathy in pediatrics: incidence, risk factors, therapeutic options, and outcome based on data from a single center.
    Kafa K; Hoell JI
    Front Oncol; 2024; 14():1399696. PubMed ID: 39050576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Case Report of Quinine-Induced Thrombotic Microangiopathy Successfully Treated With Eculizumab.
    Ng JY; Lenton D; Kerridge I; Wong C
    J Investig Med High Impact Case Rep; 2024; 12():23247096241235617. PubMed ID: 38477293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA).
    Zhang Z; Hong W; Wu Q; Tsavachidis S; Li JR; Amos CI; Cheng C; Sartain SE; Afshar-Kharghan V; Dong JF; Bhatraju P; Martin PJ; Makar RS; Bendapudi PK; Li A
    Thromb Res; 2023 May; 225():39-46. PubMed ID: 36948020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy.
    Ma S; Bhar S; Guffey D; Kim RB; Jamil M; Amos CI; Lee SJ; Hingorani SR; Sartain SE; Li A
    Transplant Cell Ther; 2023 Nov; 29(11):685.e1-685.e7. PubMed ID: 37597686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children.
    Schoettler ML; Ofori J; Bryson E; Spencer K; Qayed M; Stenger E; Bidgoli A; Chonat S; Westbrook A; Williams KM
    Transplant Cell Ther; 2024 Sep; 30(9):929.e1-929.e6. PubMed ID: 38936547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studying the Role of C5-Inhibition Therapy in Scleroderma Renal Crisis-Induced Thrombotic Microangiopathy - A Review of Literature.
    Farrukh L; Steen VD; Shapiro L; Mehta S
    Semin Arthritis Rheum; 2023 Dec; 63():152256. PubMed ID: 37689027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of eculizumab in transplantation-associated thrombotic microangiopathy: results of the French nationwide study on behalf of the SFGM-TC and the CNR-MAT.
    Peyre M; Sicre de Fontbrune F; Berceanu A; Benjemia L; Castelle M; D'Aveni M; Marçais A; Kaphan E; Bulabois CE; Sirvent A; Rohrlich PS; Coiteux V; Chantepie S; Nguyen-Quoc S; Peffault de Latour R; Coppo P
    Bone Marrow Transplant; 2024 Jul; 59(7):1034-1036. PubMed ID: 38605146
    [No Abstract]   [Full Text] [Related]  

  • 34. MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.
    Elhadad S; Chapin J; Copertino D; Van Besien K; Ahamed J; Laurence J
    Clin Exp Immunol; 2021 Jan; 203(1):96-104. PubMed ID: 32681658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in Genes Encoding Subunits of the RNA Exosome as a Potential Novel Cause of Thrombotic Microangiopathy.
    Wijnsma KL; Schijvens AM; Bouwmeester RN; Aarts LAM; van den Heuvel LBP; Haaxma CA; van de Kar NCAJ
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Efficacy and Safety of Eculizumab for Treating Myasthenia Gravis.
    Xiao H; Wu K; Liang X; Li R; Lai KP
    Front Immunol; 2021; 12():715036. PubMed ID: 34456922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.
    Heybeli C; Sridharan M; Alkhateeb HB; Villasboas Bisneto JC; Buadi FK; Chen D; Dingli D; Dispenzieri A; Gertz MA; Go RS; Hashmi SK; Hayman SR; Hogan WJ; Inwards DJ; Kenderian SS; Kumar SK; Litzow MR; Porrata LF; Lacy MQ; Micallef IN; Patnaik MM; Shah MV; Leung N
    Am J Hematol; 2020 Oct; 95(10):1170-1179. PubMed ID: 32618000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe proteinuria (but not being on dialysis) may be associated with initial inadequate complement inhibition and delayed hematological response to eculizumab therapy.
    Allinovi M; Mazzierli T; Caroti L; Antognoli G; Cirami CL
    J Nephrol; 2024 Jan; 37(1):253-256. PubMed ID: 38133742
    [No Abstract]   [Full Text] [Related]  

  • 39. Development and implementation of evidence-based, nurse-leading early warning model and healthcare quality improvement project for transplant-associated thrombotic microangiopathy: a mixed-methods, before-and-after study.
    Zhou X; Ye Y; Jin A; Pan Z; Xu Z; Ding S; Yan J; Cheng Y; Huang Y; Cao K; Xie W; Zhang J; Xu L; Zhou W; Huang L
    BMC Nurs; 2024 Aug; 23(1):535. PubMed ID: 39113009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and Efficacy of Very Early Conversion to Belatacept in Pediatric Kidney Transplantation with Transplant-Associated Thrombotic Microangiopathy: Case Study and Review of Literature.
    Acharya R; Clapp W; Upadhyay K
    Clin Pract; 2024 May; 14(3):882-891. PubMed ID: 38804401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.